Upgrade to SI Premium - Free Trial

Vor Biopharma Inc. (VOR) Reports In-Line Q3 EPS

November 7, 2024 4:25 PM

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($0.40), in-line with the analyst estimate of ($0.40).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

Categories

Earnings